Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China
An Zhu(Fujian Medical University), Zhaowei Xu(Shanghai Jiao Tong University), Min Liu(China-Japan Friendship Hospital), Siqi Yu(Fujian Medical University), Jun‐biao Xue(Shanghai Jiao Tong University), Yun-xiao Zheng(Shanghai Jiao Tong University), Huan Qi(Qingdao Institute of Bioenergy and Bioprocess Technology), Sheng‐ce Tao(Shanghai Jiao Tong University), Linfang Lu(Fujian Medical University), Xuening Wang(Shanxi Medical University), Mingxi Lin(Fujian Medical University), He‐wei Jiang(Shanghai Jiao Tong University), Xionglin Fan(Huazhong University of Science and Technology), Qing Lei(Huazhong University of Science and Technology), Bo Zhang(Tongji Hospital), Hong Chen(Shanghai Jiao Tong University), Yang Li(Ministry of Education of the People's Republic of China), Feng Wang(Tongji Hospital), Hainan Zhang(Shanghai Jiao Tong University), Sun Ziyong(Tongji Hospital), Hongyan Hou(Tongji Hospital), Ming‐liang Ma(Shanghai Jiao Tong University), Shujuan Guo(Shanghai Jiao Tong University), Qiaoyi Wu(Fujian Medical University)
Cited by 3
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
|The Lancet|2021|1.1k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study
|The Lancet Respiratory Medicine|2022|609